α-mangostin: A dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model

Antioxidants and Redox Signaling

Volumn 21, Issue 5, 2014, Pages 682-699

  Hafeez, Bilal Bin ^a   Mustafa, Ala ^a   Fischer, Joseph W ^a   Singh, Ashok ^a   Zhong, Weixiong ^a   Shekhani, Mohammed Ozair ^a   Meske, Louise ^a   Havighurst, Thomas ^b   Kim, Kyungmann ^b   Verma, Ajit Kumar ^a  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA MANGOSTIN; ANTINEOPLASTIC AGENT; CYCLIN D1; CYCLINE; GELATINASE B; GLYCOPROTEIN GP 130; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; KI 67 ANTIGEN; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; ANTIOXIDANT; MANGOSTIN; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA BINDING; EPITHELIUM CELL; FLOW CYTOMETRY; GARCINIA MANGOSTANA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; L CELL LINE; MOUSE; NONHUMAN; NUDE MOUSE; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS DUCT; PANCREAS TUMOR; PERICARP; PRIORITY JOURNAL; UNITED STATES; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; PANCREATIC NEOPLASMS; PATHOLOGY; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; CELL LINE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GARCINIA MANGOSTANA; HUMANS; INJECTIONS, INTRAPERITONEAL; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHONES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904426935     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5212     Document Type: Article

References (56)

1. Aisha AF, Abu-Salah KM, Ismail Z, and Majid AM. In vitro and in vivo anti-colon cancer effects of Garcinia mangostana xanthones extract. BMC Complement Altern Med 12: 104, 2012.
2. Akao Y, Nakagawa Y, Iinuma M, and Nozawa Y. Anticancer effects of xanthones from pericarps of mangosteen. Int J Mol Sci 9: 355-370, 2008.
3. Algül H, Adler G, and Schmid RM. NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer. Int J Gastrointest Cancer 31: 71-78, 2012.
4. Arlt A, Gehrz A, Müerköster S, Vorndamm J, Kruse ML, Fölsch UR, and Schäfer H. Role of NF-kappaB and Akt/ PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22: 3243-3251, 2003.
5. Arlt A, Vorndamm J, Breitenbroich M, Fölsch UR, Kalthoff H, Schmidt WE, and Schäfer H. Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 20: 859-868, 2001; Erratum in: Oncogene 21: 2611, 2002.
6. Aziz MH, Manoharan HT, and Verma AK. Protein kinase C epsilon, which sensitizes skin to sun's UV radiationinduced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Cancer Res 67: 1385-1394, 2007.
7. Banerjee S, Wang Z, Kong D, and Sarkar FH. 3,3′-diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer. Cancer Res 69: 5592-5600, 2009.
8. Billadeau DD. Primers on molecular pathways. The glycogen synthase kinase-3beta. Pancreatology 7: 398-402, 2007.
9. Block KM, Hanke NT, Maine EA, and Baker AF. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines. Pancreas 41: 773-781, 2012.
10. Huang C, Yang G, Jiang T, Huang K, Cao J, and Qiu Z. Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro. J Exp Clin Cancer Res 29: 51, 2010.
11. Chandler NM, Canete JJ, and Callery MP. Increased expression of NF-kappa B subunits in human pancreatic cancer cells. J Surg Res 118: 9-14, 2004.
12. Chao AC, Hsu YL, Liu CK, and Kuo PL. α-Mangostin, a dietary xanthone, induces autophagic cell death by activating the AMP-activated protein kinase pathway in glioblastoma cells. J Agric Food Chem 59: 2086-2096, 2011.
13. Chen LG, Yang LL, and Wang CC. Anti-inflammatory activity of Mangostins from Garcinia mangostana. Food Chem Toxicol 46: 688-693, 2008.
14. Chugh R, Sangwan V, Patil SP, Dudeja V, Dawra RK, Banerjee S, Schumacher RJ, Blazar BR, Georg GI, Vickers SM, and Saluja AK. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer. Sci Transl Med 4: 156ra139, 2012.
15. Darnell JE. Validating Stat3 in cancer therapy. Nat Med 11: 595-596, 2005.
16. Devi Sampath P and Vijayaraghavan K. Cardioprotective effect of alpha-Mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenolinduced myocardial infarction in rats. J Biochem Mol Toxicol 21: 336-339, 2007.
17. Doi H, Shibata MA, Shibata E, Morimoto J, Akao Y, Iinuma M, Tanigawa N, and Otsuki Y. Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer. Anticancer Res 29: 2485-2495, 2009.
18. Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, and Chiao PJ. The function of multiple IkappaB NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. Oncogene 21: 6510-6519, 2002.
19. Durlik M and Gardian K. Metalloproteinase 2 and 9 activities in the development of pancreatic cancer. Pol Przegl Chir 84: 377-382, 2012.
20. Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, and Chiao PJ. Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. Oncogene 22: 1365-1370, 2003.
21. Fukuda A, Wang SC, Morris JP 4th, Folias AE, Liou A, Kim GE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ, and Hebrok M. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19: 441-455, 2011.
22. Germain D and Frank DA. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin Cancer Res 13: 5665-5669, 2007.
23. Gialeli C, Theocharis AD, and Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278: 16-27, 2011.
24. Greten FR, Weber CK, Greten TF, Schneider G, Wagner M, Adler G, and Schmid RM. Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology 123: 2052-2063, 2002.
25. Grivennikov SI and Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 20: 65-71, 2010.
26. Hafeez BB, Imtiaz IA, Asim M, Malik A, Afaq F, Adhami VM, Saleem M, and Mukhtar H. Delphinidin, a major anthocyanidin present in pigmented fruits and vegetables inhibits the prostate cancer cells xenograft in athymic nude mice. Cancer Res 68: 8564-8572, 2008.
27. Hafeez BB, Jamal MS, Fischer JW, Mustafa A, and Verma AK. Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways. Int J Cancer 131: 2175-2186, 2012.
28. Halliwell B and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142: 231-255, 2004.
29. Holcomb B, Yip-Schneider M, and Schmidt CM. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy. Pancreas 36: 225-235, 2008.
30. This reference has been deleted. 31. Hung SH, Shen KH, Wu CH, Liu CL, and Shih YW. Alpha-Mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway. J Agric Food Chem 57: 1291-1298, 2009.
31. Johnson JJ, Petiwala SM, Syed DN, Rasmussen JT, Adhami VM, Siddiqui IA, Kohl AM, and Mukhtar H. α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis 33: 413-419, 2012.
32. Key TJ. Fruit and vegetables and cancer risk. Br J Cancer 104: 6-11, 2011.
33. Kong R, Sun B, Jiang H, Pan S, Chen H, Wang S, Krissansen GW, and Sun X. Downregulation of nuclear factorkappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer. Cancer Lett 291: 90-98, 2010.
34. Krajarng A, Nakamura Y, Suksamrarn S, and Watanapokasin R. α-Mangostin induces apoptosis in human chondrosarcoma cells through downregulation of ERK/JNK and Akt signaling pathway. J Agric Food Chem 59: 5746-5754, 2011.
35. Kurose H, Shibata MA, Iinuma M, and Otsuki Y. Alterations in cell cycle and induction of apoptotic cell death in breast cancer cells treated with α-Mangostin extracted from mangosteen pericarp. J Biomed Biotechnol 2012: 672428, 2012.
36. Lee YB, Ko KC, Shi MD, Liao YC, Chiang TA, Wu PF, Shih YX, and Shih YW. alpha-Mangostin, a novel dietary xanthone, suppresses TPA-mediated MMP-2 and MMP-9 expressions through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells. J Food Sci 75: H13-H23, 2010.
37. Maier HJ, Schmidt-Strassburger U, Huber MA, Wiedemann EM, Beug H, and Wirth T. NF-kappaB promotes epithelialmesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Lett 295: 214-228, 2010.
38. Matsumoto K, Akao Y, Yi H, Ohguchi K, Ito T, Tanaka T, Kobayashi E, Iinuma M, and Nozawa Y. Preferential target is mitochondria in alpha-Mangostin-induced apoptosis in human leukemia HL60 cells. Bioorg Med Chem 12: 5799-5806, 2004.
39. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, and Parulekar W. National Cancer Institute of Canada Clinical Trials Group. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25: 1960-1966, 2007.
40. Murtaza I, Saleem M, Adhami VM, Hafeez BB, and Mukhtar H. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAILmediated apoptosis in chemoresistant human pancreatic cancer cells. Cancer Res 69: 1156-1165, 2009.
41. Nabandith V, Suzui M, Morioka T, Kaneshiro T, Kinjo T, Matsumoto K, Akao Y, Iinuma M, and Yoshimi N. Inhibitory effects of crude alpha-Mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat. Asian Pac J Cancer Prev 5: 433-438, 2004.
42. Obolskiy D, Pischel I, Siriwatanametanon N, and Heinrich M. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res 23: 1047-1065, 2009.
43. Park JK, Ryu JK, Lee JK, Yoon WJ, Lee SH, Kim YT, and Yoon YB. Gemcitabine chemotherapy versus 5-fluorouracilbased concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer. Pancreas 33: 397-402, 2006.
44. Rigg AS and Lemoine NR. Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo. Cancer Gene Ther 8: 869-878, 2001.
45. Sahu RP and Srivastava SK. The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. J Natl Cancer Inst 101: 176-193, 2009.
46. Sakagami Y, Iinuma M, Piyasena KG, and Dharmaratne HR. Antibacterial activity of Alpha-Mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine 12: 203-208, 2005.
47. Shibata M, Iinuma M, Morimoto J, Kurose H, Akamatsu K, Okuno Y, Akao Y, Otsuki Y. α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation. BMC Med. 9: 69, 2011.
48. Shih YW, Chien ST, Chen PS, Lee JH, Wu SH, and Yin LT. Alpha-Mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells. Cell Biochem Biophys 58: 31-44, 2010.
49. Siegel R, Naishadham D, and Jemal A. Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
50. Wakefield A, Soukupova J, Montagne A, Ranger J, French R, Muller WJ, and Clarkson RW. Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors. Cancer Res 73: 745-755, 2013.
51. Weichert W, Boehm M, Gekeler V, Bahra M, Langrehr J, Neuhaus P, Denkert C, Imre G, Weller C, Hofmann HP, Niesporek S, Jacob J, Dietel M, Scheidereit C, and Kristiansen G. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer 97: 523-530, 2007.
52. Wen Z, Zhong Z, and Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250, 1995.
53. Williams P, Ongsakul M, Proudfoot J, Croft K, and Beilin L. Mangostin inhibits the oxidative modification of human low density lipoprotein. Free Radic Res 23: 175-184, 1995.
54. Wong HH and Lemoine NR. Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat Rev Gastroenterol Hepatol 6: 412-422, 2009.
55. Yoshimura A, Naka T, and Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454-465, 2007.
56. Yu H and Jove R. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 4: 97-105, 2004.